BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32531115)

  • 1. Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP).
    Koch F; Salva KA; Wirtz M; Hadaschik E; Varaljai R; Schadendorf D; Roesch A
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e844-e846. PubMed ID: 32531115
    [No Abstract]   [Full Text] [Related]  

  • 2. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
    Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
    Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
    Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
    Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
    Mastrolonardo M
    Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
    Cantisani C; Paolino G; Scarnò M; Didona D; Tallarico M; Moliterni E; Losco L; Cantoresi F; Mercuri SR; Bottoniτ U; Calvieri S
    Dermatol Ther; 2018 Nov; 31(6):e12710. PubMed ID: 30253027
    [No Abstract]   [Full Text] [Related]  

  • 9. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
    Martin GM; Stockfleth E
    J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
    Van der Geer S; Krekels GA
    J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
    Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
    Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical diclofenac gel for the management of periocular actinic keratosis.
    Batra R; Sundararajan S; Sandramouli S
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):1-3. PubMed ID: 21785377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinic keratoses treated with cold atmospheric plasma.
    Wirtz M; Stoffels I; Dissemond J; Schadendorf D; Roesch A
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e37-e39. PubMed ID: 28695987
    [No Abstract]   [Full Text] [Related]  

  • 15. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
    Burkhart CN; Burkhart CG
    Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
    Gollnick H; Dirschka T; Ostendorf R; Kerl H; Kunstfeld R
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):82-89. PubMed ID: 31407414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
    Çayirli M; Köse O; Demiriz M
    Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of diclofenac for the management and treatment of actinic keratoses.
    Iraji F; Siadat AH; Asilian A; Enshaieh S; Shahmoradi Z
    Expert Opin Drug Saf; 2008 Mar; 7(2):167-72. PubMed ID: 18324879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.